$PTHS 3 SEC Filings

Filed On	Filing
20 Apr 2026	Form 3: Gay John M., Chief Financial Officer Holds 30,518 shares of Common Stock
29 Dec 2025	Form 3: Einhorn Andrew J., Director No securities owned
23 Jul 2025	Form 3: Plesha Scott M., Director No securities owned
21 Jul 2025	Form 3: Rangarao Sai, Chief Commercial Officer No securities owned
07 Jul 2025	Form 3: Greenleaf Peter, Director No securities owned
07 Jul 2025	Form 3: Pauls Matthew, Director No securities owned
07 Jul 2025	Form 3: Baxter Richard B, Director No securities owned
03 Jul 2025	Form 3: Ligand Pharmaceuticals Inc, 10% owner
15 Feb 2024	Form 3: Boswell Prayer Ltd., 10% owner Holds 459,895 shares of Common Stock
15 Feb 2024	Form 3: Motif Pharmaceuticals Ltd., 10% owner Holds 470,674 shares of Common Stock
15 Feb 2024	Form 3: Aperture Healthcare Ventures Ltd., 10% owner Holds 426,566 shares of Common Stock
15 Feb 2024	Form 3: Simmons Chia-Lin, Director
15 Feb 2024	Form 3: Ame Equities Llc, 10% owner Holds 351,163 shares of Common Stock
15 Feb 2024	Form 3: Malamut Richard, Director
15 Feb 2024	Form 3: Lang Eric, Chief Medical Officer
15 Feb 2024	Form 3: Francis Knuettel Ii, Interim CEO, CFO, Treas & Sec
15 Feb 2024	Form 3: Friedberg Ezra M, Director and 1 other Holds 500,078 shares of Common Stock
15 Feb 2024	Form 3: Davis Todd C, Director

Comments